Announce Date | 11/12/2024 |
EPS Normalized Actual | $0.15 (Beat by $0.04) |
EPS GAAP Actual | $0.15 (Beat by $0.04) |
Revenue Actual | $0.243817B |
Revenue Surprise | Beat by $243.817M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0.57 | 189.35 | 0.5311 | 0.59993 | 3 |
Dec 2027 | 0.44 | 245.3 | 0.40998 | 0.4631 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Oct 2024) | 0.16 | 0.16 | 0.243817B | 27.33% | 243.82M |
FQ3 2024 (Jul 2024) | 0.17 | 0.17 | 0.233495B | 24.82% | 233.5M |
FQ3 2022 (Jul 2022) | -0.0725 | -0.0725 | 0.135915B | 100% | 135.92M |
FQ1 2024 (Mar 2024) | 0.89 | 0.89 | 0.3338B | 100% | 333.8M |
FQ4 2023 (Dec 2023) | 0.0175 | 0.0175 | 0.17717B | 26.66% | 177.17M |
FQ2 2023 (Apr 2023) | -0.0221 | -0.0221 | 0.203083B | 21.7% | 203.08M |
FQ3 2023 (Sep 2023) | 0.06 | 0.06 | 0.175553B | 22.58% | 175.55M |
FQ4 2021 (Dec 2021) | 0 | 0 | 0.117166B | 100% | 117.17M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 0.095511 | -- | 0.08869442 | 0.10134 | 1 |
FQ4 2026 (Oct 2026) | 0.22106 | -- | 0.20528 | 0.23454 | 1 |
FQ3 2026 (Jul 2026) | 0.24024 | -- | 0.22309 | 0.25489 | 1 |
FQ2 2026 (Apr 2026) | 0.21115 | -- | 0.19608 | 0.22403 | 1 |
FQ1 2026 (Jan 2026) | 0.07395 | -- | 0.06867222 | 0.07845985 | 1 |
FQ4 2025 (Oct 2025) | 0.1745 | 8.31 | 0.16205 | 0.18514 | 2 |
FQ3 2025 (Sep 2025) | 0.10571 | -60.82 | 0.10139 | 0.11038 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 0.32B | -- | 0.3B | 0.33B | 3 |
FQ4 2026 (Oct 2026) | 0.35B | -- | 0.33B | 0.36B | 3 |
FQ3 2026 (Jul 2026) | 0.34B | -- | 0.32B | 0.36B | 3 |
FQ2 2026 (Apr 2026) | 0.39B | -- | 0.37B | 0.41B | 4 |
FQ1 2026 (Jan 2026) | 0.26B | -- | 0.25B | 0.28B | 5 |
FQ4 2025 (Oct 2025) | 0.29B | 16.65 | 0.28B | 0.31B | 4 |
FQ3 2025 (Sep 2025) | 0.25B | 7.54 | 0.24B | 0.26B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Oct 2024) | 0.16 | 0.16 | 100% | |
FQ3 2024 (Jul 2024) | 0.17 | 0.17 | 100% | |
FQ3 2022 (Jul 2022) | -0.0725 | -0.0725 | 100% | |
FQ1 2024 (Mar 2024) | 0.89 | 0.89 | 100% | |
FQ4 2023 (Dec 2023) | 0.0175 | 0.0175 | 100% | |
FQ2 2023 (Apr 2023) | -0.0221 | -0.0221 | 100% | |
FQ3 2023 (Sep 2023) | 0.06 | 0.06 | 100% | |
FQ4 2021 (Dec 2021) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Oct 2024) | $0B | $0.24B | $243.82M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0.23B | $233.5M | 100% |
FQ3 2022 (Jul 2022) | $0B | $0.14B | $135.92M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.33B | $333.8M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.18B | $177.17M | 100% |
FQ2 2023 (Apr 2023) | $0B | $0.2B | $203.08M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.18B | $175.55M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.12B | $117.17M | 100% |